IMP_A_SDB fundamentals
Key facts
Market capitalization1.94 BSEK
Basic EPS (TTM)−3.85SEK
Founded2015
CEOPeter Forsell
Websiteimplantica.com
About
Implantica AG engages in the provision of effective care for serious health conditions and improving patient quality of life by bringing advanced technology into the body. Its product RefluxStop, is a passive CE-marked implant for prevention of gastroesophageal reflux. The company was founded by Peter Forsell in 2015 and is headquartered in Vaduz, Liechtenstein.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
−1,950.00%
−1,600.00%
−1,250.00%
−900.00%
−550.00%
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
−105.00 M
−70.00 M
−35.00 M
0.00
35.00 M
Revenue
Net income
Net margin %
Revenue breakdown
Revenue streams and regions a business earns money from
Estimates
Revenue and Earnings forecasts and estimates accuracy
Dividends
Dividend yield, history and sustainability
IMP_A_SDB does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company